Background: Under-reporting is a major issue of ADR spontaneous reporting system. This study assesses the knowledge, attitude, and practice of healthcare professionals in Children’s Hospital in Vietnam and suggests solutions to enhance ADR reporting rate based on findings. Methods: A cross-sectional study was conducted and 397 self-administered structured questionnaires were distributed to all potential HCPs working in surveyed hospital within 2 weeks from June 03 to June 20, 2020. Results: Overall response rate was 97% with 384 responses. A majority answered correctly ADRs’ knowledge apart from form supplier (1.6%) and possible causes (2.6%). The need to focus on patient care (33.3%) and the trivia of reaction (31.5%) reduced HCPs’ attention. About 61.7% reported once in their career, 49.7% had training. Having trained group had numbers of practice significantly higher than their counterparts. Major reason for not reporting was lack of information and instruction. Preferred solutions were regularly training, updating, and collaboration of HCPs in reporting ADR. Conclusion: Healthcare professionals had adequate knowledge, positive attitude, and moderate practice. Training significantly raised the number of practices in reporting ADR. Preferred solutions were regular training, updating, and collaboration of healthcare professionals in ADR reporting.
KongkaewCNoycePRAshcroftDM.Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008;42(7):1017-1025.
4.
LundkvistJJonssonB.Pharmacoeconomics of adverse drug reactions. Fundam Clin Pharmacol. 2004;18:275-280.
5.
PirmohamedMBreckenridgeAMKitteringhamNRParkBK.Fortnightly review: adverse drug reactions. BMJ. 1998;316:1295-1298.
6.
LazarouJPomeranzBHCoreyPN.Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200-1205.
7.
SchatzStephanie N.WeberRobert J.Adverse Drug Reactions. In: MurphyJohn E.LeeMary Wun-Len, ed. PSAP 2015 Book 2 CNS/Pharmacy Practice: Pharmacotherapy Self-Assessment Program. Kansas: American College of Clinical Pharmacy. 2015:5-26.
8.
GautierSBacheletHBordetRCaronJ.The cost of adverse drug reactions. Expert Opin Pharmacother. 2003;4(3):319-326.
9.
ClassenDCPestotnikSLEvansRSLloydJFBurkeJP.Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301-306.
Lopez-GonzalezEHerdeiroMTFigueirasA.Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Safety. 2009;32(1):19-31.
12.
BeltonKJLewisSCPayneSRawlinsMDWoodSM.Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol. 1995;39(3):223-226.
13.
BeltonKJ.Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group. Eur J Clin Pharmacol. 1997;52(6):423-427.
14.
OshikoyaKAAwobusuyiJO.Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009;9(1):14.
15.
HasfordJGoettlerMMunterKHMüller-OerlinghausenB.Physicians’ knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol. 2002;55(9):945-950.
16.
WilliamsDFeelyJ.Underreporting of adverse drug reactions: attitudes of Irish doctors. Ir J Med Sci. 1999;168(4):257-261.
17.
ChatterjeeSLyleNGhoshS.A survey of the knowledge, attitude and practice of adverse drug reaction reporting by clinicians in eastern India. Drug Safety. 2006;29(7):641-642.
18.
BiriellCEdwardsIR.Reasons for reporting adverse drug reactions—some thoughts based on an international review. Pharmacoepidemiol Drug Saf. 1997;6(1):21-26.
19.
National Drug Information and Adverse Drug Reactions Monitoring Centre in Vietnam. Introduction of the National Drug Information and Adverse Drug Reactions Monitoring Centre in Vietnam. Published 2010. Accessed September 19, 2020. https://bit.ly/3twqDQk
20.
National Drug Information and Adverse Drug Reactions Monitoring Centre in Vietnam. Summary pharmacovigilance activities from 2012-2016. Published 2016. Accessed September 18, 2020. http://magazine.canhgiacduoc.org.vn/Magazine/Details/177
Uppsala Monitoring Centre, World Health Organization Collaborating Centre for International Drug Monitoring. Safety monitoring of medicinal products: guidelines for setting up and running a pharmacovigilance centre. Published 2000.Accessed September 19, 2020. https://www.who-umc.org/media/1703/24747.pdf
23.
SuwankesawongWDhippayomTTan-KoiWCKongkaewC.Pharmacovigilance activities in ASEAN countries. Pharmacoepidemiol Drug Saf. 2016;25(9):1061-1069.
MontastrucJLSommetALacroixI, et al. Pharmacovigilance for evaluating adverse drug reactions: value, organization and methods. Joint Bone Spine. 2006;73:629-632.
26.
WiseLParkinsonJRaineJBreckenridgeA.New approaches to drug safety: a pharmacovigilance tool kit. Nat Rev Drug Discov. 2009;8(10):779-782.
27.
HazellLShakirSA.Under-reporting of adverse drug reactions: a systematic review. Drug Safety. 2006;29(5):385-396.
28.
Asia-Pacific Network for Enterovirus Surveillance. Children Hospital No.1 in Ho Chi Minh City, Vietnam. Published 2019. Accessed August 12, 2020. https://bit.ly/3z3VSDE
29.
CharanJBiswasT.How to calculate sample size for different study designs in medical research?Indian J Psychol Med. 2013;35(2):121-126.
30.
LaiQP.Assessment of Practice of Reporting ADR on Pediatrics Patients in National Database and Assessment of Perceptions, Attitudes of Healthcare Professionals Towards Pharmacovigilance in Vietnam National Children’s Hospital. Bachelor Graduation Thesis. Hanoi University of Pharmacy; 2014. Accessed September 20, 2020. https://bit.ly/3E6ncVu
RaviSPSubishPMishraP, et al. Teaching pharmacovigilance to medical students and doctors. Indian J Pharmacol. 2006;38(5):316-319.
39.
CoxARMarriottJFWilsonKAFernerRE.Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes. J Clin Pharm Ther. 2004;29(1):31-35.
40.
EkmanEBäckströmM.Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden. Eur J Clin Pharmacol. 2009;65:43-46.
41.
KcSTragulpiankitPGorsananSEdwardsIR.Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal. BMC Pharmacol Toxicol. 2013;14:16-16.
42.
PimpalkhuteSAJaiswalKMSontakkeSDBajaitCSGaikwadA.Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring in resident doctors of a tertiary care teaching hospital. Indian J Med Sci. 2012;66:55-61.
43.
ChopraDWardhanNRehanHS.Knowledge, attitude and practices associated with adverse drug reaction reporting amongst doctors in a teaching hospital. Int J Risk Saf Med. 2011;23:227-232.
44.
BäckströmMMjörndalTDahlqvistRNordkvist-OlssonT. Attitudes to reporting adverse drug reactions in northern Sweden. Eur J Clin Pharmacol. 2000;56:729-732.
45.
YuYMLeeEKooBS, et al. Predictive factors of spontaneous reporting of adverse drug reactions among community pharmacists. PLoS One. 2016;11(5):e0155517.
46.
HerdeiroMTFigueirasAPolóniaJGestal-OteroJJ.Influence of pharmacists’ attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Safety. 2006;29(4):331-340.
47.
HerdeiroMTFigueirasAPolóniaJGestal-OteroJJ.Physicians’ attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Safety. 2005;28(9):825-833.
48.
LeTTNguyenTTHNguyenC, et al. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam. J Clin Pharm Ther. 2020;45(1):122-127.
49.
ElandIABeltonKJvan GrootheestACMeinersAPRawlinsMDStrickerBH.Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol. 1999;48(4):623-627.
50.
DattaSSenguptaS.An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting in a tertiary care teaching hospital of Sikkim. Perspect Clin Res. 2015;6:200-206.
51.
van GrootheestACvan PuijenbroekEPde Jong-van den BergLT.Contribution of pharmacists to the reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11(3):205-210.
52.
van GrootheestKOlssonSCouperMde Jong-van den BergL. Pharmacists’ role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf. 2004;13(7):457-464.
53.
van GrootheestACde Jong-van den BergLT.The role of hospital and community pharmacists in pharmacovigilance. Res Soc Adm Pharm. 2005;1(1):126-133.
National Drug Information and Adverse Drug Reaction Monitoring Centre in Vietnam. Pharmacovigilance and drug information news. Published 2010. Accessed September 23, 2020. http://magazine.canhgiacduoc.org.vn/
National Drug Information and Adverse Drug Reaction Monitoring Centre in Vietnam. Summary of reporting ADR activities. Published 2012. Accessed September 23, 2020. https://bit.ly/390fXA0
58.
National Drug Information and Adverse Drug Reactions Monitoring Centre in Vietnam. Ministry of Health of Vietnam issuing national guidelines on pharmacovigilance. Published 2017. Accessed September 18, 2020. https://bit.ly/3A3Tv4Y
National Drug Information and Adverse Drug Reaction Monitoring Centre in Vietnam. Online issues of drug information and pharmacovigilance. Published 2008. Accessed September 22, 2020. http://magazine.canhgiacduoc.org.vn/volume/Index
61.
HanafiSTorkamandiHHayatshahiAGholamiKJavadiM.Knowledge, attitudes and practice of nurse regarding adverse drug reaction reporting. Iran J Nurs Midwifery Res. 2012;17:21-25.
62.
KiranLJShivashankaramurthyKGBhoomaSDinakarKR. Adverse drug reaction reporting among clinicians in a teaching hospital in south Karnataka. Sch J Appl Med Sci. 2014;2(1D):399-403.
63.
ElkalmiRMHassaliMAIbrahimMIWidodoRTEfanQMHadiMA.Pharmacy students’ knowledge and perceptions about pharmacovigilance in Malaysian public universities. Am J Pharm Educ. 2011;75:96.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
